Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Organoid and organ-on-a-chip technologies are rapidly advancing towards deployment for drug and toxicology screening applications. Liver and cardiac toxicities account for the majority of drug candidate failures in human trials. Liver toxicity generally produces liver cell death, while cardiac toxicity causes adverse changes in heart beat kinetics. In traditional 2D cultures, beating kinetics can be measured by electrode arrays, but in some 3D constructs, quantifying beating kinetics can be more challenging. For example, real time measurements of calcium flux or contractile forces are possible, yet rather complex. In this communication article, we demonstrate a simple sensing system based on software code that optically analyzes video capture files of beating cardiac organoids, translates these files in representations of moving pixels, and quantifies pixel movement activity over time to generate beat kinetic plots. We demonstrate this system using bioengineered cardiac organoids under baseline and drug conditions. This technology offers a non-invasive, low-cost, and incredibly simple method for tracking and quantifying beating behavior in cardiac organoids and organ-on-a-chip systems for drug and toxicology screening.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5618030PMC
http://dx.doi.org/10.3390/bios7030024DOI Listing

Publication Analysis

Top Keywords

cardiac organoids
16
beating behavior
8
drug toxicology
8
toxicology screening
8
beating kinetics
8
quantifying beating
8
cardiac
6
beating
5
optical tracking
4
tracking digital
4

Similar Publications

5-Ethynyl-2'-deoxyuridine (EdU) has revolutionized DNA replication and cell cycle analyses through fast, efficient click chemistry detection. However, commercial EdU kits suffer from high costs, proprietary formulations, limited antibody multiplexing capabilities, and difficulties with larger biological specimens. Here, we present OpenEMMU (Open-source EdU Multiplexing Methodology for Understanding DNA replication dynamics), an optimized, affordable, and user-friendly click chemistry platform utilizing off-the-shelf reagents.

View Article and Find Full Text PDF

Human cardiac organoids for disease modeling and drug discovery.

Trends Mol Med

September 2025

Board of Governors Regenerative Medicine Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA; Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA; Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA, USA; Cancer Institute, Cedars-Sinai Medica

Cardiac organoids are 3D self-assembling structures that recapitulate some of the functional, structural, and cellular aspects of the developing heart. Cardiac organoid modeling has overcome many of the limitations of current cardiac modeling systems by providing a human-relevant, multicellular, spatially advanced model that can replicate early key developmental stages of human cardiogenesis. Recent advancements in cardiac organoid modeling have enabled further understanding of cardiogenesis, cardiovascular disease, and drug-induced cardiotoxicity.

View Article and Find Full Text PDF

Mechanical strain plays a significant role in lung pathophysiology. Current two-dimensional (2D) models fail to capture the lung's dynamic mechanical environment. We developed mechanically strained 2D and more complex three-dimensional (3D) alveolar epithelial-fibroblast co-cultures and organoids using the Flexcell cell stretching bioreactor.

View Article and Find Full Text PDF

Genetic mutations affecting proteasome function can result in multi-organ diseases, such as Chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature (CANDLE) syndrome. Neurological symptoms associated with CANDLE suggest that proteasomal mutations may impact neuronal development and/or function. We generated cerebral organoids (COs) from CANDLE patient induced pluripotent stem cells (iPSCs), which exhibited impaired neuronal development when compared to COs from healthy control iPSCs.

View Article and Find Full Text PDF